Results of post-operative abdomino-pelvic radiotherapy in intermediate- and high-risk epithelial ovarian carcinoma

European Journal of Cancer Care

Volumn 17, Issue 4, 2008, Pages 371-376

  Mosalaei, A ^a,c   Kazerooni, T ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adjuvant treatment; Ovarian carcinoma; Radiotherapy

Indexed keywords

ABDOMEN; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PELVIS; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RETROSPECTIVE STUDY; SURVIVAL; TIME; TREATMENT OUTCOME;

ABDOMEN; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PELVIS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 48349118306     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2007.00871.x     Document Type: Article

References (19)

1. Dembo A.J. (1985) Abdominopelvic radiotherapy in ovarian cancer: a 10-year clinical experience. Cancer 55, 2285 2290.
2. Dembo A.J. (1992) Epithelial ovarian cancer: the role of radiotherapy. International Journal of Radiation Oncology, Biology, Physics 22, 835 845.
3. Dinniwell R., Lock M., Pintilie M., Fyles A., Laframboise S., Depetrillo D., Levin W., Manchul L., Murphy J. Oza A. (2005) Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial Ovarian cancer. International Journal of Radiation Oncology, Biology, Physics 62, 104 110.
4. Goldberg H., Stein M.E., Steiner M., Sprecher E., Beck D. Kuten A. (2001) Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: long-term follow-up. Tumori 87, 248 251.
5. Ho A.G., Beller U., Speyer J.L., Colombo N., Wernz J. Beckman EM. (1987) Reassessment of the role of secondlook laparotomy in advanced ovarian cancer. Journal of Clinical Oncology 5, 1316 1321.
6. Hoskins P.J., Swenerton K.D., Wong F., Manji MF., McMurtrie EM., Le N. Pike J. (1995) Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high- risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade). International Journal of Gynecological Cancer 5, 134 142.
7. Ledermann J.A., Dembo A.J., Sturgeon J.F., Fine S., Bush RS., Fyles AW., Pringle JF., Rawlings GA., Thomas GM. Simm J. (1991) Outcome of patients with unfavorable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation. Gynecologic Oncology 41, 30 35.
8. Lund B. Williamson P. (1990) Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma. Obstetrics and Gynecology 76, 17 22. 3.
9. Moss C. Kaye S.B. (2002) Ovarian cancer: progress and continuing controversies in management. European Journal of Cancer 38, 1701 1707.
10. Pickel H., Lahousen M., Petru E., Stettner H., Hackl A., Kapp K. Winter R. (1999) Consolidation radiotherapy after carboplatin based chemotherapy in radically operated advanced ovarian cancer. Gynecologic Oncology 72, 215 219.
11. Randall M.E., Thomas G.M. Kapp D.S. (1998) The role of radiation therapy in the management of ovarian cancer. In : Ovarian Cancer: Controversial in Management (eds Gershenson D.M. McQuire X.), pp. 219 242. Livingstone, Churchill, NY, USA.
12. Rubin S., Hoskins W., Saigo PE., Chapman D., Hakes TB., Markman M., Reichman B., Almadrones L. Lewis JL., Jr. (1991) Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecologic Oncology 42, 137 141.
13. Shimada M., Kigawa J., Kanamori Y., Itamochi H., Oishi T., Minagawa Y., Ishihara K., Takeuchi Y., Okada M. Terakawa N. (2005) Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging. International Journal of Gynecological Cancer 15, 601 605.
14. Sorbe B. (2003a) Consolidative treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. International Journal of Gynecological Cancer 13, 278 286.
15. Sorbe B. (2003b) Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy. International Journal of Gynecological Cancer 13 (Suppl. 2 192 195.
16. Thigpen J.T. (1999) Limited-stage ovarian carcinoma. Seminars in Oncology 26, 29 33. 6.
17. Vermorken J.B. (1994) Consolidation therapy in patients with advanced ovarian cancer. European Journal of Gynecological Oncology 15, 7 13.
18. Wong R., Milosevic M., Sturgeon J., Pintilie M., Fyles A., Levin W., Rosen B., Depetrillo D., Oza A., Manchul L., Murphy J. Chapman W. (1999) Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol. International Journal of Radiation Oncology, Biology, Physics 45, 657 665.
19. Young R.C. Pecorelli S. (1998) Management of early ovarian cancer. Seminars in Oncology 25, 335 339.